Filing metadata

Accession number
0001493152-21-026155
Form type
Form 3
Filer
SAB Biotherapeutics, Inc.
CIK
CIK 1833214
Filed
Oct 22, 2021
Reporting period
Oct 22, 2021
Description
Initial ownership

Explore SEC Filings Hub